Laboratoires Serobiologiques has introduced Skinasensyl, a pure tetrapeptide with an innovative and targeted mechanism especially designed for people with sensitive skin. By focusing on one specific parameter—the painful sensation experienced by end-users—Skinasensyl reduces nerve oversensitivity to external stimuli by decreasing the amount of the pro-inflammatory neuro-mediator calcitonin gene-related peptide (CGRP) that is produced by the body. This ability to inhibit CGRP release to reduce neuronal stimulation has been demonstrated in vitro to occur via binding to the µ opioid receptor.
The overall soothing effects of Skinasensyl have been confirmed in clinical studies highlighting its capability to increase the tolerance threshold of skin as well as to reduce sensations of pain and discomfort to environmental factors or known irritating agents. Skinasensyl is therefore positioned as a new generation cosmeceutical ingredient with a “pain-killer” effect, which now allows sensitive skin to have its own advanced skin care products. Available in a preservative-free version, it can also be incorporated into men’s care ranges (clinical test on a mixed panel) and is also suitable for anti-stress claim. More info: www.laboratoires-serobiologiques.com